Clinical Trials Browser

Terminated × vedolizumab × Clear all

NCT02723006 2024-03-05

Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination With Standard of Care Immune Checkpoint Inhibitors in Participants With Advanced Melanoma

Phase 1 Terminated

22 enrolled 14 charts

Melanoma

NCT02768532 2023-06-15

VEDO-PREDIRESP

Phase 4 Terminated

Crohn Disease

NCT03802214 2020-12-21

Ulcerative Colitis - Vedolizumab- With/Without Prior Exposure to Anti-TNF（Tumor Necrosis Factor）Therapy

Colitis, Ulcerative